An Open-Label Extension Study of STK-001 for Patients With Dravet Syndrome
Clinical trial NCT04740476 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04740476
- Sponsor
- Stoke Therapeutics, Inc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-20
- Primary completion
- 2029-03-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.